Leandro Augusto Tanuri
Mesa 7 - Patologias Inflamatórias 2 - Maria Vitória Pádua de Quintero
| Artigo | Autor(es) | Referência |
|---|---|---|
| Advances in the diagnosis and treatment of Sjogren's syndrome. | Chen Xiaoyun, Wu Huaxun, Wei Wei | Clinical rheumatology. 2018 Jul; 37(Jul):1743-1749. doi: 10.1007/s10067-018-4153-8. pii: . |
| Clinical practice guideline for Sjögren's syndrome 2017. | Sumida Takayuki, Azuma Naoto, Moriyama Masafumi, Takahashi Hiroyuki, Asashima Hiromitsu, Honda Fumika, Abe Saori, Ono Yuko, Hirota Tomoya, Hirata Shintaro, Tanaka Yoshiya, Shimizu Toshimasa, Nakamura Hideki, Kawakami Atsushi, Sano Hajime, Ogawa Yoko, Tsubota Kazuo, Ryo Koufuchi, Saito Ichiro, Tanaka Akihiko, Nakamura Seiji, Takamura Etsuko, Tanaka Masao, Suzuki Katsuya, Takeuchi Tsutomu, Yamakawa Noriyuki, Mimori Tsuneyo, Ohta Akiko, Nishiyama Susumu, Yoshihara Toshio, Suzuki Yasunori, Kawano Mitsuhiro, Tomiita Minako, Tsuboi Hiroto | Modern rheumatology. 2018 May; 28(May):383-408. doi: 10.1080/14397595.2018.1438093. pii: . |
| Current Insights in Microbiome Shifts in Sjogren's Syndrome and Possible Therapeutic Interventions. | Tsigalou Christina, Stavropoulou Elisavet, Bezirtzoglou Eugenia | Frontiers in immunology. 2018 ; 9():1106. doi: 10.3389/fimmu.2018.01106. pii: . |
| Highlights of the 14th International Symposium in Sjögren's Syndrome. | Bombardieri Michele, Baldini Chiara, Alevizos Ilias, Akpek Esen, Baer Alan N | Clinical and experimental rheumatology. 36 Suppl 112():3-13. |
| Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome. | Soyfoo Muhammad Shahnawaz, Chivasso Clara, Perret Jason, Delporte Christine | International journal of molecular sciences. 2018 Oct; 19(Oct):doi: 10.3390/ijms19113392. pii: E3392. |
| Limited efficacy of targeted treatments in Sjögren's syndrome: why? | Tzioufas Athanasios G, Goules Andreas V | Clinical and experimental rheumatology. 36 Suppl 112():27-28. |
| Management of primary Sjögren's syndrome: recent developments and new classification criteria. | Del Papa Nicoletta, Vitali Claudio | Therapeutic advances in musculoskeletal disease. 2018 Feb; 10(Feb):39-54. doi: 10.1177/1759720X17746319. pii: . |
| Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges. | Chen Weiqian, Yu Ye, Ma Jilin, Olsen Nancy, Lin Jin | Stem cells international. 2018 ; 2018():4357865. doi: 10.1155/2018/4357865. pii: . |
| Optimizing conventional DMARD therapy for Sjögren's syndrome. | van der Heijden E H M, Kruize A A, Radstake T R D J, van Roon J A G | Autoimmunity reviews. 2018 05; 17(05):480-492. doi: 10.1016/j.autrev.2018.03.003. pii: S1568-9972(18)30051-X. |
| Sjögren's syndrome: state of the art on clinical practice guidelines. | Romão Vasco C, Talarico Rosaria, Scirè Carlo Alberto, Vieira Ana, Alexander Tobias, Baldini Chiara, Gottenberg Jacques-Eric, Gruner Heidi, Hachulla Eric, Mouthon Luc, Orlandi Martina, Pamfil Cristina, Pineton de Chambrun Marc, Taglietti Marco, Toplak Natasa, van Daele Paul, van Laar Jacob M, Bombardieri Stefano, Schneider Matthias, Smith Vanessa, Cutolo Maurizio, Mosca Marta, Mariette Xavier | RMD open. 2018 ; 4():e000789. doi: 10.1136/rmdopen-2018-000789. pii: . |
| The value of rituximab treatment in primary Sjögren's syndrome. | Verstappen Gwenny M, van Nimwegen Jolien F, Vissink Arjan, Kroese Frans G M, Bootsma Hendrika | Clinical immunology (Orlando, Fla.). 2017 09; 182(09):62-71. doi: 10.1016/j.clim.2017.05.002. pii: S1521-6616(17)30174-2. |